Racial disparities in the use of second-generation antipsychotics for the treatment of schizophrenia

被引:49
作者
Mallinger, JB
Fisher, SG
Brown, T
Lamberti, JS
机构
[1] Univ Rochester, Dept Community & Prevent Med, Rochester, NY 14627 USA
[2] Univ Rochester, Dept Psychiat, Rochester, NY 14627 USA
关键词
D O I
10.1176/appi.ps.57.1.133
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Despite recommendations that second-generation antipsychotics be used as first-line treatment for schizophrenia, previous studies have shown that blacks are less likely than whites to receive these newer drugs. This study determined the rate at which second-generation antipsychotics were prescribed to whites and blacks with schizophrenia who were treated as outpatients. Methods: Data were collected from a community mental health clinic affiliated with an academic center in Rochester, New York. Multivariate logistic regression was used to examine the association between race and the receipt of a second-generation antipsychotic. Results: Data were available for 456 patients: 276 whites and 180 blacks. Ninety-five percent received a second-generation antipsychotic. Whites were approximately six times more likely than blacks to receive a second-generation medication, after the analysis controlled for clinical and sociodemographic factors (p < .001). Most of this difference appeared to be driven by a disparity in the use of clozapine. Conclusions: In this sample, blacks were less likely than whites to receive second-generation antipsychotics, demonstrating a persistent gap in the quality of care for patients with schizophrenia.
引用
收藏
页码:133 / 136
页数:4
相关论文
共 14 条
[1]   Sex, ethnicity, and antipsychotic medication use in patients with psychosis [J].
Arnold, LM ;
Strakowski, SM ;
Schwiers, ML ;
Amicone, J ;
Fleck, DE ;
Corey, KB ;
Farrow, JE .
SCHIZOPHRENIA RESEARCH, 2004, 66 (2-3) :169-175
[2]   Outpatient prescriptions for atypical antipsychotics for African Americans, Hispanics, and whites in the United States [J].
Daumit, GL ;
Crum, RM ;
Guallar, E ;
Powe, NR ;
Primm, AB ;
Steinwachs, DM ;
Ford, DE .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (02) :121-128
[3]   A meta-analysis of the efficacy of second-generation antipsychotics [J].
Davis, JM ;
Chen, N ;
Glick, ID .
ARCHIVES OF GENERAL PSYCHIATRY, 2003, 60 (06) :553-564
[4]   Antipsychotics: Past and future - National Institute of Mental Health Division of Services and Intervention Research Workshop, July 14, 1998 [J].
Dawkins, K ;
Lieberman, JA ;
Lebowitz, BD ;
Hsiao, JK .
SCHIZOPHRENIA BULLETIN, 1999, 25 (02) :395-404
[5]   Treatment with clozapine - Black patients' low white cell counts currently mean that they cannot be treated [J].
Fisher, N ;
Baigent, B .
BRITISH MEDICAL JOURNAL, 1996, 313 (7067) :1262-1262
[6]   Racial disparity in the pharmacological management of schizophrenia [J].
Kreyenbuhl, J ;
Zito, JM ;
Buchanan, RW ;
Soeken, KL ;
Lehman, AF .
SCHIZOPHRENIA BULLETIN, 2003, 29 (02) :183-193
[7]  
Lawson WB, 1996, PSYCHOPHARMACOL BULL, V32, P275
[8]  
Lehman AF, 2004, AM J PSYCHIAT, V161, P1
[9]   Access to new medications to treat schizophrenia [J].
Mark, TL ;
Dirani, R ;
Slade, E ;
Russo, PA .
JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 2002, 29 (01) :15-29
[10]  
Moeller F G, 1995, Ann Clin Psychiatry, V7, P167, DOI 10.3109/10401239509149622